A Single-Dose, Randomized, Open-Label, Parallel Design Study to Characterize the Pharmacokinetics of an Investigational Olanzapine Intranasal Spray Compared to a Reference Dose of Olanzapine Intramuscular Injection in Healthy Adult Males
Year: 2025
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.4088/jcp.24m15665
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4408617525
